Bavarian Biotech Report 2011/2012 (7MB) - Bio M

More documents

Recommendations

Info

TILL Photonics GmbHBIOTECH DEVICES & REAGENTSKeywords: Devices, Microscopy, AutomationContact:Erika WeberLochhamer Schlag 21D-82166 GräfelfingPhone: +49 (0) 89 895662-0Fax: +49 (0) 89 895662-101E-Mail: info@till-photonics.comInternet: www.till-photonics.comTILL Photonics GmbH, founded in 1993, develops and markets live cell fluorescencemicroscopes for research applications as well as routine, appliedscience and diagnostics. The microscopes based on patented technology forconfocal and conventional fluorescence microscopy, were developed incollaboration with the BioImaging Zentrum (BIZ) at the Ludwig-Maximilians-Universität (LMU) in Munich and are manufactured in Germany. The successof TILL Photonics in the scientific as well as the routine markets is based ona competent and experienced team providing reliable instrumentation forautomated routine applications as well as collaboration with internationalresearch institutions.TILL provides extremely flexible, modular systems for all current and futuremicroscopy standards – and complete turnkey solutions for imaging andphotometry systems. The majority of TILL’s customers are found in the fieldsof neurobiology, cell biology, biomedicine and pharmacology.The company’s headquarters are located in the Munich BioRegio (Germany),TILL Photonics’ US operation is based in Rochester, NY.TopLab GmbHBIOTECH DNA/PROTEIN ANALYTICSContact:Dr. Elfriede MüllerFraunhoferstr. 18aD-82152 MartinsriedPhone: +49 (0) 89 856512-83Fax: +49 (0) 89 856512-86E-Mail: info@toplab.deInternet: www.toplab.deKeywords: Analysis, ProteomicsTOPLAB GmbH is a leading ISO 9001 certified service provider with highend research facilities for proteomics, protein analytics, target and biomarkerdiscovery and validation. The company has outstanding expertise inproteome analysis, protein identification and characterisation with morethan 15 years experience. A portfolio of proprietary technologies has beendeveloped and/or licensed that is able to significantly enhance the rate ofdiscovery of potential biomarkers and novel therapeutic targets.The vision of TOPLAB is to support our clients from pharma, biotech andacademia with highest quality standards, modern technologies and anexperienced and highly motivated team, to achieve confident results incompliance with the timelines of our customers with calculable costs.114
Transcatheter Technologies GmbHBIOTECH DEVICES & REAGENTSKeywords: Devices, Cardiovascular DiseasesTRANSCATHETER TECHNOLOGIES develops medical devices aimed at reducingthe trauma of open-heart valve surgeries. Its re-positionable transcatheteraortic valve system TRINITY is at the forefront of next generation valveimplantation technology. The new technology makes it possible to implantaortic valve prostheses without the need for traumatic open-heart surgery.Key features of TRINITY allow the physician to reposition the valve duringimplantation. ZERO PRESSURE CRIMPING technology protects the fragilebiological leaflets when the stent is folded and expanded. This will increasethe safety and durability of the valve prosthesis and will allow for implantationin younger patients.Contact:Dr. Wolfgang GoetzJosef-Engert-Str. 13D-93051 RegensburgPhone: +49 (0) 170 63099-20Fax: +49 (0) 941 63099-897E-Mail:wolfgang.goetz@transcathetertechnologies.comInternet: www.transcatheter-technologies.comTRION Pharma GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Immune Therapy, Antibody, Drug DevelopmentTRION Pharma GmbH is a privately held biopharmaceutical company thathas established a novel approach to cancer immunotherapy. The Company’sunique family of trifunctional therapeutic antibodies, called Triomab ® ,simultaneously activates multiple immune defense mechanisms againstcancer. Removab ® (catumaxomab), the most advanced candidate of theTriomab ® family, received EU market approval for the intraperitoneal treatmentof malignant ascites. Removab ® is not only the first drug indicated forthe treament of malignant ascites, but also the first approved bispecific,trifunctional antibody worldwide. TRION employs about 90 people in Munichfor development and cGMP-manufacturing of its antibody products.Contact:Brigitte StempferFrankfurter Ring 193aD-80807 MünchenPhone: +49 (0) 89 324266-0Fax: +49 (0) 89 324266-199E-Mail: mail@trionpharma.deInternet: www.trionpharma.deTRION Research GmbHBIOTECH DNA/PROTEIN ANALYTICSKeywords: Drug Development, Antibody Production Service, Immune TherapyTRION Research GmbH, founded in 1998, is a Biotech research company and astrategic partner of TRION Pharma GmbH focusing on the generation of novelTriomab ® antibody candidates and the support of non-clinical and clinicaldevelopment of Triomab ® antibodies. The company offers ImmunomonitoringService, special antibody conjugation support, additional analytical service intumor biology and further analytical support for reagent control to investigators,study sponsors and CROs. TRION Research is ISO 9001:2008 certified.The core competences of the company are:Immunomonitoring and logistical support for clinical and non-clinical studiesSupply of purified antibodies (labeled and unlabeled) Developmentof immunological assaysContact:Brigitte StempferAm Klopferspitz 19D-82152 MartinsriedPhone: +49 (0) 89 700766-0Fax: +49 (0) 89 700766-11E-Mail: mail@trionresearch.deInternet: www.trionresearch.com115
Page 2 and 3:
Our research benefits your health.T
Page 4 and 5:
ImprintEditorial staff: Georg Kää
Page 6 and 7:
Select IMGM as your outsourcing par
Page 8 and 9:
The 2011 Biotech Year in Bavaria -A
Page 10 and 11:
Due to this focus that was establis
Page 12 and 13:
Furthermore, the continued interest
Page 14 and 15:
Last but not least, the IZB start-u
Page 16 and 17:
Company FoundationsMerck-Sharp & Do
Page 18 and 19:
Total number of employees in the Ba
Page 20 and 21:
PHASE II4SC: Hepatocellular carcino
Page 22 and 23:
Deals, Cooperation, Mergers, Financ
Page 24 and 25:
M&A-ActivityIn early 2011 the acqui
Page 26:
Due to the increasing number of new
Page 29:
one so called “innovation allianc
Page 32 and 33:
4SC AGBIOTECH THERAPEUTICS & DIAGNO
Page 34 and 35:
Contact:Dr. Luc St-OngeFraunhoferst
Page 36 and 37:
Contact:Dr. Lars WassillWerkstr. 2D
Page 38 and 39:
Apceth GmbH & Co. KGBIOTECH THERAPE
Page 40 and 41:
Contact:Dr. Gundel HagerBahnhofstr.
Page 42 and 43:
Bernina Plus GmbHBIOTECH THERAPEUTI
Page 44 and 45:
Biontex Laboratories GmbHBIOTECH DE
Page 46 and 47:
Carl Zeiss MicroImaging GmbHBIOTECH
Page 48 and 49:
ChemDiv, Inc.CROContact:Dr. Anna Ni
Page 50 and 51:
conoGenetix biosciences GmbHBIOTECH
Page 52 and 53:
CoreLab Partners Europe GmbHCROCont
Page 54 and 55:
Davids Biotechnologie GmbHBIOTECH D
Page 56 and 57:
Dynamic BiosensorsBIOTECH DNA/PROTE
Page 58 and 59:
Contact:Uschi LangGoethestr. 4D-803
Page 60 and 61:
Eurofins MWG OperonBIOTECH DNA/PROT
Page 62 and 63:
FGK Clinical Research GmbHCROContac
Page 64 and 65: GeneArt AGBIOTECHContact:Prof. Dr.
Page 66 and 67: Contact:Dr. Korbinian GroteBayerstr
Page 68 and 69: Contact:Peter Paul SchikoraMühlfel
Page 70 and 71: Contact:Kurt MartinJosef-Engert-Str
Page 72 and 73: ibidi GmbHBIOTECH DEVICES & REAGENT
Page 74 and 75: Immumed GmbH -Gesellschaft für ang
Page 76 and 77: INHECO GmbHBIOTECH DEVICES & REAGEN
Page 78 and 79: IRIS Biotech GmbHPHARMA & CHEMICAL
Page 80 and 81: KLIFOVET AGCROContact:Dr. Klaus Hel
Page 82 and 83: LEUKOCARE AGBIOTECH DEVICES & REAGE
Page 84 and 85: medicomp GmbHCROContact:Dr. med. ve
Page 86 and 87: Contact:Dr. Erwin SoutschekFlorians
Page 88 and 89: MLL Münchner Leukämie Labor GmbHB
Page 90 and 91: multimmune GmbHBIOTECH THERAPEUTICS
Page 92 and 93: NanoScape AGPHARMA & CHEMICAL INDUS
Page 94 and 95: nexttec GmbHBIOTECH DNA/PROTEIN ANA
Page 96 and 97: Contact:Michael AlmstetterAm Klopfe
Page 98 and 99: PAN Biotech GmbHBIOTECH DEVICES & R
Page 100 and 101: Pharma Stulln GmbHPHARMA & CHEMICAL
Page 102 and 103: Phytochem Referenzsubstanzen GbRmbH
Page 104 and 105: PreSens Precision Sensing GmbHBIOTE
Page 106 and 107: Contact:Dr. Torsten NeuefeindBunsen
Page 108 and 109: Ridom GmbHBIOTECH BIOINFORMATICSCon
Page 110 and 111: SERVIER Deutschland GmbHPHARMA & CH
Page 112 and 113: SSS International Clinical Research
Page 116 and 117: Tripos InternationalBIOTECH BIOINFO
Page 118 and 119: vertis Biotechnologie AGBIOTECH DNA
Page 120 and 121: Wilex AGBIOTECH THERAPEUTICS & DIAG
Page 124: Where the future becomes realityHOT
show all

Bavarian Biotech Report 2011/2012 (7MB) - Bio M

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?